Free Trial

Feedback (FDBK) Competitors

Feedback logo
GBX 19.78 -0.02 (-0.10%)
As of 01/21/2025 11:15 AM Eastern

FDBK vs. INHC, TRLS, IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, and RENX

Should you be buying Feedback stock or one of its competitors? The main competitors of Feedback include Induction Healthcare Group (INHC), Trellus Health (TRLS), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry.

Feedback vs.

Induction Healthcare Group (LON:INHC) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, analyst recommendations, valuation, dividends, risk, profitability, earnings and media sentiment.

46.3% of Induction Healthcare Group shares are held by institutional investors. Comparatively, 53.2% of Feedback shares are held by institutional investors. 54.6% of Induction Healthcare Group shares are held by company insiders. Comparatively, 10.8% of Feedback shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Induction Healthcare Group has higher revenue and earnings than Feedback. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Induction Healthcare Group£13.65M0.56-£3.25M-£0.03-270.37
Feedback£1.18M2.23-£3.30M-£0.25-79.12

Feedback received 151 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 67.07% of users gave Feedback an outperform vote.

CompanyUnderperformOutperform
Induction Healthcare GroupOutperform Votes
14
93.33%
Underperform Votes
1
6.67%
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%

In the previous week, Induction Healthcare Group's average media sentiment score of 0.00 equaled Feedback'saverage media sentiment score.

Company Overall Sentiment
Induction Healthcare Group Neutral
Feedback Neutral

Induction Healthcare Group has a beta of -0.41, indicating that its share price is 141% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500.

Induction Healthcare Group has a net margin of -23.86% compared to Feedback's net margin of -279.16%. Induction Healthcare Group's return on equity of -14.53% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Induction Healthcare Group-23.86% -14.53% -7.32%
Feedback -279.16%-35.63%-22.99%

Summary

Induction Healthcare Group beats Feedback on 8 of the 13 factors compared between the two stocks.

Get Feedback News Delivered to You Automatically

Sign up to receive the latest news and ratings for FDBK and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FDBK vs. The Competition

MetricFeedbackHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£2.64M£200.41M£5.39B£2.04B
Dividend Yield4.56%6.94%5.37%5.16%
P/E Ratio-79.12537.3688.831,926.65
Price / Sales2.23828.491,282.28384,006.48
Price / Cash1.1247.1436.6029.21
Price / Book0.355.404.963.08
Net Income-£3.30M-£8.11M£117.89M£183.60M
7 Day Performance0.41%1.17%2.75%3.09%
1 Month Performance17.35%14.21%3.63%3.42%
1 Year Performance-71.33%15.45%27.27%165.41%

Feedback Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
N/AGBX 19.78
-0.1%
N/A-71.3%£2.64M£1.18M-79.1224
INHC
Induction Healthcare Group
N/AGBX 8.17
-3.9%
N/A-56.2%£7.66M£13.65M-272.1774
TRLS
Trellus Health
N/AGBX 2.25
+275.0%
N/A-50.0%£3.63M£35,000.00-75.0031Gap Up
High Trading Volume
IQAI
IQ-AI
N/AGBX 1.40
-12.2%
N/A-46.9%£3.10M£538,190.00-13.676
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.9189 of 5 stars
GBX 2,080
-1.4%
GBX 2,700
+29.8%
+3.6%£735.07M£189.27M8,000.00734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
3.0371 of 5 stars
GBX 180
-0.3%
GBX 585
+225.0%
-39.0%£65.66M£54.17M1,500.00478Positive News
RENX
Renalytix
N/AGBX 11.65
-2.9%
N/A+1.3%£19.33M£2.29M-48.54102Gap Down

Related Companies and Tools


This page (LON:FDBK) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners